Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by CAMERON, J. S.
Right arrow Articles by LEIBOWITZ, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CAMERON, J. S.
Right arrow Articles by LEIBOWITZ, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Q J Med 1979; 48: 1-24
© 1979 Association of Physicians

research-article

Systemic Lupus with Nephritis: A Long-Term Study

J. S. CAMERON, D. R. TURNER, C. S. OGG, D. G. WILLIAMS, M. H. LESSOF, C. CHANTLER and S. LEIBOWITZ

Departments of Medicine, Paediatrics and Pathology, Guys Hospital London

Accepted for publication 28 June 1978.

Seventy-one patients with systemic lupus erythematosus and clinical evidence of nephritis were seen during a 15-year period, and followed for a mean of seven years. Survival was calculated to be 76 per cent at five years and 57 per cent at ten years from onset of clinical nephritis; and 80, 65, 55 and 55 per cent five, ten, fifteen and twenty years from onset of clinical lupus. Renal biopsies showed mild or focal lesions in 30 per cent of patients, membranous lesions in 14 per cent and diffuse proliferative lesions in 55 per cent. However, there was no difference in the long-term outcome of the different histological groups. Nineteen patients (27 per cent) died during follow up, eleven from renal failure, six from sepsis and two from cerebral lupus. Death in renal failure is now usually a late event in lupus even in patients with clinical evidence of severe nephritis.

The prognosis of even severe lupus nephritis is now better than formerly reported. Reducing the dose of corticosteroid drugs, by the use of cytotoxic drugs such as azathio prine may have diminished the mortality from cardiovascular complications. Side effects of treatment, however, remain an important cause of death and morbidity.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 LupusHome page
D. Chen, C. Hsieh, K. Chen, Y. Chen, F. Lin, and J. Lan
Association of interleukin-18 promoter polymorphisms with WHO pathological classes and serum IL-18 levels in Chinese patients with lupus nephritis
Lupus, January 1, 2009; 18(1): 29 - 37.
[Abstract] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. D. Smet, D. Kuypers, P. Evenepoel, B. Maes, T. Messiaen, B. V. Damme, and Y. Vanrenterghem
Full house' positive immunohistochemical membranoproliferative glomerulonephritis in a patient with portosystemic shunt
Nephrol. Dial. Transplant., November 1, 2001; 16(11): 2258 - 2262.
[Full Text] [PDF]

Home page
 QJMHome page
L. Bono, J.S. Cameron, and J.A. Hicks
The very long-term prognosis and complications of lupus nephritis and its treatment
QJM, April 1, 1999; 92(4): 211 - 218.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
M. M. Ward and S. Studenski
Clinical Prognostic Factors in Lupus Nephritis: The Importance of Hypertension and Smoking
Arch Intern Med, October 1, 1992; 152(10): 2082 - 2088.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.